SCHEMBL1830

SCHEMBL1830

Cc1noc(-c2ccc(-c3ccc(OC(=O)C4CC4)cc3)cc2)c1CNC[C@H](C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.40
LPAR1 Q92633 5/20 0.40
LPAR3 Q9UBY5 2/20 0.39
SLCO1B1 Q9Y6L6 2/20 0.38
ABCC3 O15438 1/20 0.38
ABCC4 O15439 1/20 0.38
ABCB11 O95342 1/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2C9 P11712 1/20 0.38
ABCB4 P21439 1/20 0.38
ABCC2 Q92887 1/20 0.38
SLCO1B3 Q9NPD5 1/20 0.38
HTT P42858 1/20 0.38
ELANE P08246 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
BCHE P06276 1/20 0.36
TP53 P04637 2/20 0.36
LPAR2 Q9HBW0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1788 0.79 LPAR1 (0.58) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL1829 0.79 LPAR1 (0.58) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL1690 0.77 LPAR1 (0.40) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL1691 0.77 LPAR1 (0.40) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL2502 0.77 LPAR1 (0.50) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL1582 0.77 LPAR1 (0.50) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL6863 0.77 SLC6A9 (0.43) SLC6A9LPAR1LPAR3SLCO1B1HTT
SCHEMBL28398519 0.71 LPAR1 (0.49) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL1663 0.70 LPAR1 (0.56) LPAR1LPAR3SLCO1B1ABCC3ABCC4
SCHEMBL1680146 0.70 BRD4 (0.38) SLC6A9LPAR1LPAR3SLCO1B1ABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483253-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP claimed
WO-2011041729-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO claimed